|
| |
BioPortfolio's Approved Drugs DatabaseIdarubicin HydrochlorideIdarubicin HydrochlorideDownload PDF containing detailed information.
Press Releases About Idarubicin Hydrochloride:
|
 |
| Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) |
19th November, 2009 |
AEGERA THERAPEUTICS INC. |
MONTREAL, Nov. 19 /PRNewswire/ - Aegera Therapeutics Inc. announced today the dosing of the first patient in a randomized Phase 2B study of AEG35156, a targeted antisense therapeutic in mid-stage
|
| Caraco Pharmaceutical Laboratories, Ltd. Markets Nicardipine Hydrochloride Injection |
18th November, 2009 |
Caraco Pharmaceutical Laboratories, Ltd. |
DETROIT, Nov. 18 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) has launched Nicardipine Hydrochloride Injection immediately following Sun Pharma's final
|
| Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results |
17th November, 2009 |
Jiangbo Pharmaceuticals, Inc. |
LAIYANG, China, Nov. 17 /PRNewswire-Asia-FirstCall/ -- Jiangbo
Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) ("Jiangbo" or the "Company"),
a pharmaceutical company with its
|
| China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 |
16th November, 2009 |
China Shenghuo Pharmaceutical Holdings, Inc. |
KUNMING, China, Nov. 16 /PRNewswire-Asia-FirstCall/ -- China Shenghuo
Pharmaceutical Holdings, Inc. (NYSE Amex Equities: KUN) ("China Shenghuo" or
the "Company"), which is
|
| Bioniche Pharma and Academic Pharmaceuticals, Inc. Announce the Introduction of Sotalol Hydrochloride Injection |
16th November, 2009 |
Bioniche Pharma |
LAKE FOREST, Ill. and LAKE BLUFF, Ill., Nov. 16 /PRNewswire/ -- Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals, and Academic Pharmaceuticals, Inc (API), a research
|
Companies working in the area of Idarubicin Hydrochloride from Bioportfolio's Biocorporate database : | |
| Company Name | |
Solux Corporation is an International Pharmaceutical Company with the focus on innovative development of generic Active Pharmaceutical Ingredients (APIs) for oncology and acute-care hospital market....
www.soluxsolutions.com View full profile
| |
This page has been viewed 35 times
Recent Search Terms used to find this page: .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Idarubicin Hydrochloride across BioPortfolio, or for Idarubicin Hydrochloride Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
